Lam Research Corporation (NASDAQ:LRCX) Receives $200.52 Average PT from Brokerages

Shares of Lam Research Corporation (NASDAQ:LRCX) have received a consensus recommendation of “Moderate Buy” from the thirty-five research firms that are presently covering the stock, Marketbeat reports. Seven equities research analysts have rated the stock with a hold rating, twenty-seven have given a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $204.2645.

Several research analysts recently issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $265.00 target price (up from $210.00) on shares of Lam Research in a research report on Thursday, January 8th. Susquehanna reaffirmed a “positive” rating and set a $250.00 price target on shares of Lam Research in a research note on Monday, January 12th. The Goldman Sachs Group reiterated a “buy” rating and set a $180.00 price objective on shares of Lam Research in a research report on Friday, January 9th. Citigroup reissued a “buy” rating and set a $265.00 price objective (up from $190.00) on shares of Lam Research in a report on Thursday, January 22nd. Finally, Barclays set a $195.00 target price on Lam Research in a research note on Thursday, January 15th.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 earnings and revenue beat consensus — Lam reported $1.27 EPS vs. $1.17 expected and $5.34B revenue vs. $5.23B expected, with margins and ROE notably strong (y/y revenue +22%). Lam Research (LRCX) Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Raised Q3 guidance: EPS guide $1.25–1.45 (above $1.20 consensus) and revenue guide $5.4–6.0B (above ~$5.3B consensus) — investors view this as confirmation of stronger WFE demand. Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2025
• Positive Sentiment: Management and news outlets cite rising enterprise orders and strong chipmaking-tool demand underpinning the upbeat forecast — a demand-driven beat/guide is taken as durable upside for revenue visibility. Lam Research forecasts strong quarterly results on chipmaking tool demand
• Positive Sentiment: Analyst interest and upgrades: coverage notes (including Evercore/other firms) and at least one upgrade have lifted sentiment and trading interest. Lam Research (NASDAQ:LRCX) Stock Price Up 2.3% After Analyst Upgrade
• Positive Sentiment: High-profile bullish commentary — Jim Cramer and others highlight a supply shortage and structural tailwinds from AI and advanced-node spending, supporting a longer-term bullish case. Lam Research (LRCX) Has a Shortage That Can’t Be Met, Says Jim Cramer
• Neutral Sentiment: Positive media and analyst previews (Zacks, 24/7 Wall St.) framed expectations ahead of results — helpful for market context but not new fundamentals. Bull of the Day: Lam Research (LRCX)
• Negative Sentiment: Valuation and volatility concerns — commentary warns that LRCX is at record highs and has a history of sharp corrections; investors should weigh upside vs. PE/volatility risk. Why Record Highs For LRCX Stock May Face A Reality Check In 2026
• Negative Sentiment: Geopolitical/China exposure — coverage notes that China-related demand or regulatory developments could weigh on the outlook despite AI tailwinds. Lam Research leans on AI tailwinds as China weighs on outlook

Lam Research Stock Performance

Shares of LRCX opened at $239.58 on Monday. Lam Research has a 12-month low of $56.32 and a 12-month high of $243.99. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The company has a market cap of $300.92 billion, a PE ratio of 52.77, a price-to-earnings-growth ratio of 3.01 and a beta of 1.77. The stock has a 50-day moving average price of $183.31 and a 200-day moving average price of $144.37.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the firm posted $0.91 earnings per share. Lam Research’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities analysts forecast that Lam Research will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s dividend payout ratio is 22.91%.

Insiders Place Their Bets

In related news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 41,408 shares of company stock worth $6,248,501. 0.31% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Lam Research

Several institutional investors and hedge funds have recently bought and sold shares of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research in the fourth quarter worth approximately $25,000. IMG Wealth Management Inc. bought a new stake in Lam Research during the 2nd quarter valued at $26,000. Stance Capital LLC purchased a new stake in Lam Research during the 3rd quarter valued at $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research in the 2nd quarter worth $27,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the third quarter valued at about $27,000. 84.61% of the stock is currently owned by institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.